Mitochon Pharmaceuticals Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Investors
  • 5

Mitochon Pharmaceuticals General Information

Description

Operator of a biotechnology platform intended to develop drugs that target the mitochondria for a host of severe diseases with significant unmet medical needs. The company's platform offers a pipeline of drugs that are designed to improve mitochondrial function and protect cells from damage, enabling customers to get the treatment they need for serious diseases that have limited treatment options.

Contact Information

Website
www.mitochonpharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 970 Cross Lane
  • Blue Bell, PA 19422
  • United States
+1 (215)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 970 Cross Lane
  • Blue Bell, PA 19422
  • United States
+1 (215)

Mitochon Pharmaceuticals Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mitochon Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC Cancelled Clinical Trials - Phase 2
8. Secondary Transaction - Private 17-Feb-2023 Completed Clinical Trials - Phase 2
7. Grant 10-May-2022 Completed Clinical Trials - Phase 2
6. Later Stage VC 13-Jul-2021 Completed Clinical Trials - Phase 2
5. Early Stage VC 30-Nov-2019 Completed Clinical Trials - Phase 2
4. Angel (individual) 21-Dec-2017 Completed Pre-Clinical Trials
3. Grant 03-Oct-2017 Completed Pre-Clinical Trials
2. Early Stage VC 17-May-2016 $1.6M $2.35M Completed Pre-Clinical Trials
1. Early Stage VC 31-Mar-2015 $750K $750K Completed Pre-Clinical Trials
To view Mitochon Pharmaceuticals’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Mitochon Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology platform intended to develop drugs that target the mitochondria for a host of severe disease
Drug Discovery
Blue Bell, PA
4 As of 2024

San Diego, CA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mitochon Pharmaceuticals Competitors (16)

One of Mitochon Pharmaceuticals’s 16 competitors is Epirium Bio, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Epirium Bio Venture Capital-Backed San Diego, CA
Mitobridge Formerly VC-backed Cambridge, MA
Volastra Venture Capital-Backed New York, NY
Avalyn Pharma Venture Capital-Backed Cambridge, MA
Ona Therapeutics Venture Capital-Backed Barcelona, Spain
You’re viewing 5 of 16 competitors. Get the full list »

Mitochon Pharmaceuticals Patents

  • 35

    Total Documents Applications and Grants

  • Total Patents Families

  • 23

    Granted

  • 9

    Pending

  • Expiring in next 12 mo

Mitochon Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11406642-B2 Dnp and dnp prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases Active 07-Mar-2016
AU-2017229224-B2 Dnp and dnp prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, concussion, dry eye disease, and/or metabolic diseases Active 07-Mar-2016
AU-2017229224-A1 Dnp and dnp prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, concussion, dry eye disease, and/or metabolic diseases Active 07-Mar-2016
US-20170252347-A1 Dnp and dnp prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases Active 07-Mar-2016
EP-3426233-A4 Dnp and dnp prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, concussion, dry eye disease, and/or metabolic diseases Pending 07-Mar-2016 A61K31/06
To view Mitochon Pharmaceuticals’s complete patent history, request access »

Mitochon Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mitochon Pharmaceuticals Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Emily's Entourage Not-For-Profit Venture Capital
Cures Within Reach Corporation Minority
Michael J. Fox Foundation Limited Partner
Ben Franklin Technology Partners of Southeastern Pennsylvania Accelerator/Incubator Minority
YT Angels Angel Group Minority
To view Mitochon Pharmaceuticals’s complete investors history, request access »

Ready to get started?

Request a free trial

Mitochon Pharmaceuticals FAQs

  • When was Mitochon Pharmaceuticals founded?

    Mitochon Pharmaceuticals was founded in 2014.

  • Where is Mitochon Pharmaceuticals headquartered?

    Mitochon Pharmaceuticals is headquartered in Blue Bell, PA.

  • What is the size of Mitochon Pharmaceuticals?

    Mitochon Pharmaceuticals has 4 total employees.

  • What industry is Mitochon Pharmaceuticals in?

    Mitochon Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Mitochon Pharmaceuticals a private or public company?

    Mitochon Pharmaceuticals is a Private company.

  • What is Mitochon Pharmaceuticals’s current revenue?

    The current revenue for Mitochon Pharmaceuticals is .

  • How much funding has Mitochon Pharmaceuticals raised over time?

    Mitochon Pharmaceuticals has raised $5.25M.

  • Who are Mitochon Pharmaceuticals’s investors?

    Emily's Entourage, Cures Within Reach, Michael J. Fox Foundation, Ben Franklin Technology Partners of Southeastern Pennsylvania, and YT Angels have invested in Mitochon Pharmaceuticals.

  • Who are Mitochon Pharmaceuticals’s competitors?

    Epirium Bio, Mitobridge, Volastra, Avalyn Pharma, and Ona Therapeutics are some of the 16 competitors of Mitochon Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »